Literature DB >> 23534463

Potent in vitro interference of fleroxacin in DNA-binding, unwinding and ATPase activities of Bloom helicase.

Heng Luo1, Hou Qiang Xu, Xiang Chen, Mei Ding, Qi Xin Yang, Kun Li.   

Abstract

OBJECTIVE: To study the effect of fleroxacin (FLRX) on biological properties of Bloom (BLM) helicase catalytic core (BLM642-1290 helicase) in vitro and the molecular mechanism of interaction between the two molecules.
METHODS: DNA-binding and unwinding activities of BLM642-1290 helicase were assayed by fluorescence polarization and gel retardation assay under conditions that the helicase was subjected to different concentrations of FLRX. Effect of FLRX on helicase ATPase activity was analyzed by phosphorus-free assay based on a colorimetric estimation of ATP hydrolysis-produced inorganic phosphate. Molecular mechanism of interaction between the two molecules was assayed by ultraviolet and fluorescence spectra.
RESULTS: The DNA unwinding and ATPase activities of BLM642-1290 helicase were inhibited whereas the DNA-binding activity was promoted in vitro. A BLM-FLRX complex was formed through one binding site, electrostatic and hydrophobic interaction force. Moreover, the intrinsic fluorescence of the helicase was quenched by FLRX as a result of non-radioactive energy transfer. The biological activity of helicase was affected by FLRX, which may be through an allosteric mechanism and stabilization of enzyme conformation in low helicase activity state, disruption of the coupling of ATP hydrolysis to unwinding, and blocking helicase translocation on DNA strands.
CONCLUSION: FLRX may affect the biological activities and conformation of BLM642-1290 helicase, and DNA helicase may be used as a promising drug target for some diseases.
Copyright © 2013 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  BLM helicase; Biological activity; Fleroxacin; Interaction mechanism

Mesh:

Substances:

Year:  2013        PMID: 23534463     DOI: 10.3967/0895-3988.2013.04.001

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  1 in total

1.  Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase.

Authors:  Wangming Zhang; Shuang Yang; Jinhe Liu; Linchun Bao; He Lu; Hong Li; Weidong Pan; Yanchao Jiao; Zhixu He; Jielin Liu
Journal:  BMC Cancer       Date:  2019-10-28       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.